Identification of a Novel Osteogenetic Oligodeoxynucleotide (osteoDN) That Promotes Osteoblast Differentiation in a TLR9-Independent Manner
Dysfunction of bone-forming cells, osteoblasts, is one of the causes of osteoporosis. Accumulating evidence has indicated that oligodeoxynucleotides (ODNs) designed from genome sequences have the potential to regulate osteogenic cell fate. Such osteogenetic ODNs (osteoDNs) targeting and activating o...
| Main Authors: | , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2022-05-01
|
| Series: | Nanomaterials |
| Subjects: | |
| Online Access: | https://www.mdpi.com/2079-4991/12/10/1680 |
| _version_ | 1797497309213229056 |
|---|---|
| author | Yuma Nihashi Mana Miyoshi Koji Umezawa Takeshi Shimosato Tomohide Takaya |
| author_facet | Yuma Nihashi Mana Miyoshi Koji Umezawa Takeshi Shimosato Tomohide Takaya |
| author_sort | Yuma Nihashi |
| collection | DOAJ |
| description | Dysfunction of bone-forming cells, osteoblasts, is one of the causes of osteoporosis. Accumulating evidence has indicated that oligodeoxynucleotides (ODNs) designed from genome sequences have the potential to regulate osteogenic cell fate. Such osteogenetic ODNs (osteoDNs) targeting and activating osteoblasts can be the candidates of nucleic acid drugs for osteoporosis. In this study, the ODN library derived from the <i>Lacticaseibacillus rhamnosus</i> GG genome was screened to determine its osteogenetic effect on murine osteoblast cell line MC3T3-E1. An 18-base ODN, iSN40, was identified to enhance alkaline phosphatase activity of osteoblasts within 48 h. iSN40 also induced the expression of osteogenic genes such as Msx2, osterix, collagen type 1α, osteopontin, and osteocalcin. Eventually, iSN40 facilitated calcium deposition on osteoblasts at the late stage of differentiation. Intriguingly, the CpG motif within iSN40 was not required for its osteogenetic activity, indicating that iSN40 functions in a TLR9-independent manner. These data demonstrate that iSN40 serves as a novel osteogenetic ODN (osteoDN) that promotes osteoblast differentiation. iSN40 provides a potential seed of the nucleic acid drug that activating osteoblasts for osteoporosis therapy. |
| first_indexed | 2024-03-10T03:16:36Z |
| format | Article |
| id | doaj.art-c126998845944ec3800f5e9de803d5e7 |
| institution | Directory Open Access Journal |
| issn | 2079-4991 |
| language | English |
| last_indexed | 2024-03-10T03:16:36Z |
| publishDate | 2022-05-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Nanomaterials |
| spelling | doaj.art-c126998845944ec3800f5e9de803d5e72023-11-23T12:26:33ZengMDPI AGNanomaterials2079-49912022-05-011210168010.3390/nano12101680Identification of a Novel Osteogenetic Oligodeoxynucleotide (osteoDN) That Promotes Osteoblast Differentiation in a TLR9-Independent MannerYuma Nihashi0Mana Miyoshi1Koji Umezawa2Takeshi Shimosato3Tomohide Takaya4Department of Science and Technology, Graduate School of Medicine, Science and Technology, Shinshu University, 8304 Minami-minowa, Kami-ina, Nagano 399-4598, JapanDepartment of Agriculture, Graduate School of Science and Technology, Shinshu University, 8304 Minami-minowa, Kami-ina, Nagano 399-4598, JapanDepartment of Agricultural and Life Sciences, Faculty of Agriculture, Shinshu University, 8304 Minami-minowa, Kami-ina, Nagano 399-4598, JapanDepartment of Science and Technology, Graduate School of Medicine, Science and Technology, Shinshu University, 8304 Minami-minowa, Kami-ina, Nagano 399-4598, JapanDepartment of Science and Technology, Graduate School of Medicine, Science and Technology, Shinshu University, 8304 Minami-minowa, Kami-ina, Nagano 399-4598, JapanDysfunction of bone-forming cells, osteoblasts, is one of the causes of osteoporosis. Accumulating evidence has indicated that oligodeoxynucleotides (ODNs) designed from genome sequences have the potential to regulate osteogenic cell fate. Such osteogenetic ODNs (osteoDNs) targeting and activating osteoblasts can be the candidates of nucleic acid drugs for osteoporosis. In this study, the ODN library derived from the <i>Lacticaseibacillus rhamnosus</i> GG genome was screened to determine its osteogenetic effect on murine osteoblast cell line MC3T3-E1. An 18-base ODN, iSN40, was identified to enhance alkaline phosphatase activity of osteoblasts within 48 h. iSN40 also induced the expression of osteogenic genes such as Msx2, osterix, collagen type 1α, osteopontin, and osteocalcin. Eventually, iSN40 facilitated calcium deposition on osteoblasts at the late stage of differentiation. Intriguingly, the CpG motif within iSN40 was not required for its osteogenetic activity, indicating that iSN40 functions in a TLR9-independent manner. These data demonstrate that iSN40 serves as a novel osteogenetic ODN (osteoDN) that promotes osteoblast differentiation. iSN40 provides a potential seed of the nucleic acid drug that activating osteoblasts for osteoporosis therapy.https://www.mdpi.com/2079-4991/12/10/1680osteogenetic oligodeoxynucleotide (osteoDN)osteoblastbone differentiationcalcificationmineralizationToll-like receptor 9 (TLR9) |
| spellingShingle | Yuma Nihashi Mana Miyoshi Koji Umezawa Takeshi Shimosato Tomohide Takaya Identification of a Novel Osteogenetic Oligodeoxynucleotide (osteoDN) That Promotes Osteoblast Differentiation in a TLR9-Independent Manner Nanomaterials osteogenetic oligodeoxynucleotide (osteoDN) osteoblast bone differentiation calcification mineralization Toll-like receptor 9 (TLR9) |
| title | Identification of a Novel Osteogenetic Oligodeoxynucleotide (osteoDN) That Promotes Osteoblast Differentiation in a TLR9-Independent Manner |
| title_full | Identification of a Novel Osteogenetic Oligodeoxynucleotide (osteoDN) That Promotes Osteoblast Differentiation in a TLR9-Independent Manner |
| title_fullStr | Identification of a Novel Osteogenetic Oligodeoxynucleotide (osteoDN) That Promotes Osteoblast Differentiation in a TLR9-Independent Manner |
| title_full_unstemmed | Identification of a Novel Osteogenetic Oligodeoxynucleotide (osteoDN) That Promotes Osteoblast Differentiation in a TLR9-Independent Manner |
| title_short | Identification of a Novel Osteogenetic Oligodeoxynucleotide (osteoDN) That Promotes Osteoblast Differentiation in a TLR9-Independent Manner |
| title_sort | identification of a novel osteogenetic oligodeoxynucleotide osteodn that promotes osteoblast differentiation in a tlr9 independent manner |
| topic | osteogenetic oligodeoxynucleotide (osteoDN) osteoblast bone differentiation calcification mineralization Toll-like receptor 9 (TLR9) |
| url | https://www.mdpi.com/2079-4991/12/10/1680 |
| work_keys_str_mv | AT yumanihashi identificationofanovelosteogeneticoligodeoxynucleotideosteodnthatpromotesosteoblastdifferentiationinatlr9independentmanner AT manamiyoshi identificationofanovelosteogeneticoligodeoxynucleotideosteodnthatpromotesosteoblastdifferentiationinatlr9independentmanner AT kojiumezawa identificationofanovelosteogeneticoligodeoxynucleotideosteodnthatpromotesosteoblastdifferentiationinatlr9independentmanner AT takeshishimosato identificationofanovelosteogeneticoligodeoxynucleotideosteodnthatpromotesosteoblastdifferentiationinatlr9independentmanner AT tomohidetakaya identificationofanovelosteogeneticoligodeoxynucleotideosteodnthatpromotesosteoblastdifferentiationinatlr9independentmanner |